| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_69ece09bafee7e0c49d1f7951a3faa2c |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4985 |
| filingDate |
2021-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e88bc6a04008ca406bf80b13efc9bf55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e68bd627bbc7216fb019abd40f30e0d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df9c65c4f503c39a51459058b27d5cd4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4cf7fd7acb39d2d08762d2ebfad1bbec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11be7c77d3b119e792d3b9b13fd6aa8d |
| publicationDate |
2022-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2022093820-A1 |
| titleOfInvention |
Substituted morpholine compounds |
| abstract |
Described herein are compounds of Formula (A), and solvates and pharmaceutically acceptable salts thereof. Further described herein are methods of using said compounds, such as in the treatment of a hyperproliferative disorder in a subject in need thereof. |
| priorityDate |
2020-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |